Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Oertel

Showing results (421-430 of 585) with videos related to

Pageof 59
Sort By:
Epilepsy Research|June 13, 2009
Etiology and site of temporal lobe epilepsy influence postictal cytokine releaseSebastian Bauer, Sabine Cepok, Anelia Todorova-Rudolph, et al.
BMC Neurology|October 6, 2010
Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patchBirgit Högl, Wolfgang H Oertel, Karin Stiasny-Kolster, et al.
Neuroscience Letters|December 14, 2011
Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's diseaseCarmen Noelker, Michael Schwake, Monika Balzer-Geldsetzer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 10, 2020
Four-Year Follow-up of [<sup>18</sup> F]Fluorodeoxyglucose Positron Emission Tomography-Based Parkinson's Disease-Related Pattern Expression in 20 Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder Shows Prodromal ProgressionRosalie V Kogan, Annette Janzen, Sanne K Meles, et al.
Neuroscience|May 17, 2011
Caffeic acid phenethyl ester prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegenerationC V Fontanilla, Z Ma, X Wei, et al.
Neurology|August 26, 2006
Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR)W H Oertel, H Benes, R Bodenschatz, et al.
Plos One|May 3, 2013
Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse modelDaniel Alvarez-Fischer, Carmen Noelker, Franca Vulinović, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2017
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorderAnna Heintz-Buschart, Urvashi Pandey, Tamara Wicke, et al.
Neuroimage|August 25, 2007
Quantitative [(123)I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's diseaseD Alvarez-Fischer, G Blessmann, C Trosowski, et al.
Seizure|January 24, 2012
Minocycline as potent anticonvulsant in a patient with astrocytoma and drug resistant epilepsyM Nowak, A Strzelczyk, P S Reif, et al.
Pageof 59

Showing results (421-430 of 585) with videos related to

Sort By:
Pageof 59
Epilepsy Research|June 13, 2009
Etiology and site of temporal lobe epilepsy influence postictal cytokine releaseSebastian Bauer, Sabine Cepok, Anelia Todorova-Rudolph, et al.
BMC Neurology|October 6, 2010
Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patchBirgit Högl, Wolfgang H Oertel, Karin Stiasny-Kolster, et al.
Neuroscience Letters|December 14, 2011
Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's diseaseCarmen Noelker, Michael Schwake, Monika Balzer-Geldsetzer, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 10, 2020
Four-Year Follow-up of [<sup>18</sup> F]Fluorodeoxyglucose Positron Emission Tomography-Based Parkinson's Disease-Related Pattern Expression in 20 Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder Shows Prodromal ProgressionRosalie V Kogan, Annette Janzen, Sanne K Meles, et al.
Neuroscience|May 17, 2011
Caffeic acid phenethyl ester prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegenerationC V Fontanilla, Z Ma, X Wei, et al.
Neurology|August 26, 2006
Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR)W H Oertel, H Benes, R Bodenschatz, et al.
Plos One|May 3, 2013
Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse modelDaniel Alvarez-Fischer, Carmen Noelker, Franca Vulinović, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2017
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorderAnna Heintz-Buschart, Urvashi Pandey, Tamara Wicke, et al.
Neuroimage|August 25, 2007
Quantitative [(123)I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's diseaseD Alvarez-Fischer, G Blessmann, C Trosowski, et al.
Seizure|January 24, 2012
Minocycline as potent anticonvulsant in a patient with astrocytoma and drug resistant epilepsyM Nowak, A Strzelczyk, P S Reif, et al.
Pageof 59